Balance Sheet British American Tobacco p.l.c.

Equities

BATS

GB0002875804

Tobacco

Market Closed - London S.E. Other stock markets 16:35:06 08/05/2026 BST			5-day change	1st Jan Change
4,267.00 ^GBX	-0.44%		-1.43%	+1.26%

05-08	Trump Plans to Fire FDA Commissioner Makary	MT
05-08	Trump Plans to Fire FDA Commissioner Makary	MT

11d1c828ee3077fc7a439f7c52.GRi2OhfzncKBqMZz4CEagGi1GPuY4DJm8PZvoG2_9Hg.KFf9aVCk9Jby7q4nixBwxz3fIZ-v1wcOl7AW6RjTxCEucNtUI5_klNPJgw

Published financial data: BRITISH AMERICAN TOBACCO P.L.C.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	25.68B	27.66B	27.28B	25.87B	25.61B
Total Revenues	25.68B	27.66B	27.28B	25.87B	25.61B
Cost of Goods Sold, Total	4.6B	4.8B	4.89B	4.57B	4.44B
Gross Profit	21.09B	22.85B	22.39B	21.3B	21.17B
Selling General & Admin Expenses, Total	3.81B	3.83B	3.86B	3.95B	4.2B
Depreciation & Amortization - (IS)	938M	962M	849M	2.23B	2.21B
Other Operating Expenses	5.34B	6.41B	5.05B	5.32B	5B
Other Operating Expenses, Total	10.09B	11.2B	9.75B	11.5B	11.41B
Operating Income	11B	11.65B	12.64B	9.8B	9.76B
Interest Expense, Total	-1.5B	-1.66B	-1.83B	-1.77B	-1.77B
Interest And Investment Income	35M	92M	186M	251M	214M
Net Interest Expenses	-1.47B	-1.57B	-1.65B	-1.52B	-1.56B
Income (Loss) On Equity Invest.	415M	442M	585M	1.9B	1.68B
Currency Exchange Gains (Loss)	171M	-491M	432M	-2M	360M
Other Non Operating Income (Expenses)	-166M	324M	-618M	-111M	-666M
EBT, Excl. Unusual Items	9.95B	10.36B	11.39B	10.06B	9.57B
Restructuring Charges	-150M	-774M	2M	-	-66M
Merger & Related Restructuring Charges	-	-	-	-	-
Impairment of Goodwill	-57M	-	-4.61B	-39M	-277M
Gain (Loss) On Sale Of Investments	-24M	-	-	-6M	21M
Gain (Loss) On Sale Of Assets	-358M	6M	-546M	62M	22M
Asset Writedown	-92M	-123M	-23.11B	-828M	-37M
Legal Settlements	-81M	-144M	-156M	-6.3B	601M
Other Unusual Items	-26M	-	-29M	590M	24M
EBT, Incl. Unusual Items	9.16B	9.32B	-17.06B	3.54B	9.86B
Income Tax Expense	2.19B	2.48B	-2.87B	357M	2.09B
Earnings From Continuing Operations	6.97B	6.85B	-14.19B	3.18B	7.76B
Net Income to Company	6.97B	6.85B	-14.19B	3.18B	7.76B
Minority Interest	-173M	-180M	-178M	-113M	-1M
Net Income - (IS)	6.8B	6.67B	-14.37B	3.07B	7.76B
Preferred Dividend and Other Adjustments	12M	49M	45M	42M	87M
Net Income to Common Incl Extra Items	6.79B	6.62B	-14.41B	3.03B	7.68B
Net Income to Common Excl. Extra Items	6.79B	6.62B	-14.41B	3.03B	7.68B
Per Share Items
Net EPS - Basic	2.97	2.93	-6.47	1.37	3.51
Basic EPS - Continuing Operations	2.97	2.93	-6.47	1.37	3.51
Basic Weighted Average Shares Outstanding	2.29B	2.26B	2.23B	2.21B	2.19B
Net EPS - Diluted	2.96	2.92	-6.47	1.36	3.49
Diluted EPS - Continuing Operations	2.96	2.92	-6.47	1.36	3.49
Diluted Weighted Average Shares Outstanding	2.3B	2.27B	2.23B	2.22B	2.2B
Normalized Basic EPS	2.64	2.79	3.11	2.79	2.73
Normalized Diluted EPS	2.63	2.78	3.11	2.78	2.72
Dividend Per Share	2.16	2.18	2.36	2.4	2.45
Payout Ratio	72.2	73.73	-35.6	171.74	68.16
American Depositary Receipts Ratio (ADR)	0.2	0.2	0.2	0.2	0.2
Supplemental Items
EBITDA	11.94B	12.18B	13.28B	11.82B	11.76B
EBITA	11B	11.65B	12.88B	11.45B	11.36B
EBIT	11B	11.65B	12.64B	9.8B	9.76B
EBITDAR	11.95B	12.2B	13.29B	11.83B	11.77B
Effective Tax Rate - (Ratio)	23.89	26.58	16.83	10.09	21.24
Current Domestic Taxes	-25M	-3M	32M	103M	99M
Current Foreign Taxes	2.4B	2.72B	2.78B	2.68B	2.06B
Total Current Taxes	2.38B	2.72B	2.81B	2.78B	2.16B
Total Deferred Taxes	-187M	-240M	-5.68B	-2.42B	-64M
Normalized Net Income	6.05B	6.29B	6.94B	6.18B	5.98B
Interest on Long-Term Debt	24M	25M	30M	38M	40M
Non-Cash Pension Expense	-28M	-29M	-33M	-39M	11M
Supplemental Operating Expense Items
Marketing Expenses	1.24B	1.16B	1.15B	1.11B	1.09B
Selling and Marketing Expenses	1.24B	1.16B	1.15B	1.11B	1.09B
Research And Development Expense From Footnotes	304M	323M	408M	380M	358M
Net Rental Expense, Total	9M	12M	14M	9M	9M
Imputed Operating Lease Interest Expense	2.59M	3.85M	4.91M	3.32M	3.55M
Imputed Operating Lease Depreciation	6.41M	8.15M	9.09M	5.68M	5.45M
Stock-Based Comp., SG&A Exp. (Total)	78M	85M	-	74M	90M
Total Stock-Based Compensation	78M	85M	-	74M	90M

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	2.81B	3.45B	4.66B	5.3B	3.83B
Short Term Investments	-	-	-	-	-
Trading Asset Securities, Total	456M	579M	601M	513M	16M
Total Cash And Short Term Investments	3.26B	4.02B	5.26B	5.81B	3.84B
Accounts Receivable, Total	3B	2.61B	2.89B	2.86B	3.08B
Other Receivables	1.07B	1.91B	906M	816M	1.19B
Total Receivables	4.07B	4.52B	3.79B	3.67B	4.27B
Inventory	5.28B	5.67B	4.94B	4.62B	4.38B
Other Current Assets, Total	195M	1.2B	195M	197M	187M
Total Current Assets	12.81B	15.41B	14.19B	14.29B	12.68B
Gross Property Plant And Equipment	8.97B	9.51B	9.04B	8.85B	9.28B
Accumulated Depreciation	-4.02B	-4.64B	-4.46B	-4.47B	-4.79B
Net Property Plant And Equipment	4.95B	4.87B	4.58B	4.38B	4.48B
Long-term Investments	2B	2.14B	2.09B	2.05B	1.85B
Goodwill	43.19B	47.96B	41.09B	41.13B	38.92B
Other Intangibles, Total	72.43B	81.12B	54.47B	53.15B	48.02B
Deferred Tax Assets Long-Term	611M	682M	911M	2.57B	2.03B
Other Long-Term Assets, Total	1.37B	1.37B	1.39B	1.33B	1.3B
Total Assets	137B	154B	119B	119B	109B
Liabilities
Accounts Payable, Total	3.92B	4.06B	1.71B	1.71B	1.81B
Accrued Expenses, Total	14M	14M	13M	11M	11M
Short-term Borrowings	346M	106M	-	138M	37M
Current Portion of Long-Term Debt	3.52B	4.16B	4.19B	4.03B	3.17B
Current Portion of Leases	126M	142M	131M	141M	153M
Current Income Taxes Payable	879M	1.05B	992M	1.68B	1.13B
Other Current Liabilities	6.34B	8.32B	8.64B	11.03B	8.21B
Total Current Liabilities	15.14B	17.85B	15.67B	18.74B	14.52B
Long-Term Debt	35.35B	38.35B	35.23B	32.19B	31.33B
Long-Term Leases	320M	375M	367M	444M	376M
Pension & Other Post Retirement Benefits	1.27B	979M	910M	851M	825M
Deferred Tax Liability Non Current	16.46B	18.43B	12.19B	11.68B	10.34B
Other Non Current Liabilities	1.43B	1.85B	1.41B	4.99B	3.74B
Total Liabilities	69.96B	77.84B	65.78B	68.9B	61.14B
Preferred Stock - Others	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	614M	614M	614M	585M	577M
Additional Paid In Capital	107M	113M	115M	121M	123M
Retained Earnings	49.33B	51.2B	31.63B	26.02B	27.31B
Treasury Stock	-5.12B	-7.12B	-7.1B	-4.41B	-4.38B
Comprehensive Income and Other	22.17B	30.56B	27.31B	27.33B	24.3B
Total Common Equity	67.1B	75.37B	52.57B	49.64B	47.93B
Minority Interest	300M	342M	368M	352M	219M
Total Equity	67.4B	75.71B	52.93B	50B	48.14B
Total Liabilities And Equity	137B	154B	119B	119B	109B
Supplemental Items
ECS Total Shares Outstanding on Filing Date	2.29B	2.23B	2.23B	2.2B	2.17B
ECS Total Common Shares Outstanding	2.29B	2.23B	2.23B	2.2B	2.17B
Book Value / Share	28.59	33.04	22.81	21.77	21.18
Tangible Book Value	-48.52B	-53.71B	-43B	-44.63B	-39.01B
Tangible Book Value Per Share	-21.94	-24.84	-20.03	-21.03	-18.82
Total Debt	39.66B	43.14B	39.92B	36.95B	35.07B
Net Debt	36.39B	39.11B	34.66B	31.14B	31.23B
Debt Equivalent of Unfunded Proj. Benefit Obligation	-230M	-574M	-525M	-554M	-561M
Debt Equivalent Oper. Leases	72M	96M	112M	72M	72M
Minority Interest, Total (Incl. Fin. Div)	300M	342M	368M	352M	219M
Equity Method Investments, Total	1.95B	2.02B	1.97B	1.9B	1.52B
Account Code - Inventory Valuation	6	6	6	6	6
Inventories - Raw Materials, Total	2.1B	2.37B	2.2B	2.06B	2.02B
Inventories - Finished Goods, Total	3.18B	3.3B	2.74B	2.56B	2.36B
Land - (BS)	242M	246M	-	-	-
Machinery, Total	6B	6.32B	6.08B	6B	6.34B
Full Time Employees	54.36K	52.08K	46.72K	48.99K	47.8K
Accumulated Allowance for Doubtful Accounts (Supple)	37M	51M	70M	45M	46M

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	6.8B	6.67B	-14.37B	3.07B	7.76B
Depreciation & Amortization - CF	938M	531M	492M	462M	490M
Amortization of Goodwill and Intangible Assets - (CF)	-	-	237M	1.65B	1.6B
Depreciation & Amortization, Total	938M	531M	729M	2.11B	2.1B
Amortization of Deferred Charges, Total - (CF)	-	-	120M	120M	119M
(Gain) Loss From Sale Of Asset	-	554M	-	-	-
Asset Writedown & Restructuring Costs	138M	220M	27.76B	867M	333M
(Income) Loss On Equity Investments - (CF)	-	-	-585M	-1.9B	-1.68B
Other Operating Activities, Total	1.9B	2.32B	-2.48B	80M	1.36B
Change In Accounts Receivable	-393M	-42M	-487M	-269M	-295M
Change In Inventories	433M	-246M	265M	35M	112M
Change In Accounts Payable	183M	3M	640M	58M	-207M
Change in Other Net Operating Assets	-285M	388M	-887M	5.95B	-3.26B
Cash from Operations	9.72B	10.39B	10.71B	10.12B	6.34B
Capital Expenditure	-527M	-523M	-460M	-486M	-551M
Sale of Property, Plant, and Equipment	31M	31M	54M	145M	37M
Cash Acquisitions	-	-	-	-	-
Divestitures	-98M	-	159M	-	4M
Sale (Purchase) of Intangible assets	-218M	-130M	-114M	-83M	-122M
Investment in Marketable and Equity Securities, Total	-361M	-168M	-80M	1.61B	1.82B
Other Investing Activities, Total	33M	85M	145M	187M	202M
Cash from Investing	-1.14B	-705M	-296M	1.38B	1.39B
Long-Term Debt Issued, Total	978M	3.27B	5.13B	2.4B	3.81B
Total Debt Issued	978M	3.27B	5.13B	2.4B	3.81B
Long-Term Debt Repaid, Total	-5B	-3.26B	-6.93B	-4.99B	-4.11B
Total Debt Repaid	-5B	-3.26B	-6.93B	-4.99B	-4.11B
Issuance of Common Stock	1.68B	-	-	-	1.05B
Repurchase of Common Stock	-82M	-2.09B	-110M	-792M	-2.06B
Common Dividends Paid	-4.91B	-4.92B	-5.11B	-5.27B	-5.29B
Common & Preferred Stock Dividends Paid	-4.91B	-4.92B	-5.11B	-5.27B	-5.29B
Other Financing Activities, Total	-1.42B	-1.87B	-2.29B	-1.98B	-2.17B
Cash from Financing	-8.75B	-8.88B	-9.31B	-10.63B	-8.76B
Foreign Exchange Rate Adjustments	-253M	431M	-292M	-281M	-76M
Miscellaneous Cash Flow Adjustments	-	-368M	368M	-	-208M
Net Change in Cash	-425M	874M	1.18B	587M	-1.32B
Supplemental Items
Cash Interest Paid	1.5B	1.6B	1.71B	1.74B	1.67B
Cash Income Tax Paid (Refund)	2.31B	2.54B	2.62B	1.85B	2.93B
Levered Free Cash Flow	6.61B	6.65B	7.41B	10.28B	2.99B
Unlevered Free Cash Flow	7.55B	7.69B	8.56B	11.39B	4.1B
Change In Net Working Capital	-404M	-446M	-381M	-3.52B	3.63B
Net Debt Issued / Repaid	-4.02B	2M	-1.8B	-2.59B	-295M

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	5	5.01	5.8	5.15	5.34
Return on Total Capital	6.43	6.45	7.45	6.81	7.17
Return On Equity %	10.7	9.57	-22.06	6.18	15.82
Return on Common Equity	10.47	9.29	-22.53	5.92	15.74
Margin Analysis
Gross Profit Margin %	82.1	82.63	82.07	82.33	82.65
SG&A Margin	14.83	13.85	14.13	15.27	16.4
EBITDA Margin %	46.48	44.05	48.66	45.7	45.91
EBITA Margin %	42.83	42.13	47.2	44.26	44.36
EBIT Margin %	42.83	42.13	46.33	37.87	38.09
Income From Continuing Operations Margin %	27.15	24.76	-52.01	12.3	30.32
Net Income Margin %	26.48	24.1	-52.66	11.86	30.32
Net Avail. For Common Margin %	26.43	23.93	-52.82	11.7	29.98
Normalized Net Income Margin	23.54	22.76	25.45	23.88	23.35
Levered Free Cash Flow Margin	25.74	24.06	27.17	39.73	11.69
Unlevered Free Cash Flow Margin	29.4	27.81	31.36	44.02	16.02
Asset Turnover
Asset Turnover	0.19	0.19	0.2	0.22	0.22
Fixed Assets Turnover	5.13	5.63	5.77	5.77	5.78
Receivables Turnover (Average Receivables)	8.92	9.86	9.93	9.01	8.63
Inventory Turnover (Average Inventory)	0.82	0.88	0.92	0.96	0.99
Short Term Liquidity
Current Ratio	0.85	0.86	0.91	0.76	0.87
Quick Ratio	0.48	0.48	0.58	0.51	0.56
Operating Cash Flow to Current Liabilities	0.64	0.58	0.68	0.54	0.44
Days Sales Outstanding (Average Receivables)	40.94	37	36.76	40.62	42.31
Days Outstanding Inventory (Average Inventory)	447.69	415.98	395.86	382.58	369.6
Average Days Payable Outstanding	359.78	280.21	156.65	147.16	152.76
Cash Conversion Cycle (Average Days)	128.85	172.77	275.97	276.04	259.15
Long Term Solvency
Total Debt/Equity	58.84	56.98	75.41	73.91	72.84
Total Debt / Total Capital	37.04	36.3	42.99	42.5	42.14
LT Debt/Equity	52.92	51.15	67.24	65.28	65.86
Long-Term Debt / Total Capital	33.31	32.58	38.33	37.54	38.1
Total Liabilities / Total Assets	50.93	50.69	55.41	57.95	55.95
EBIT / Interest Expense	7.31	7.02	6.9	5.53	5.5
EBITDA / Interest Expense	7.94	7.34	7.3	6.72	6.68
(EBITDA - Capex) / Interest Expense	7.59	7.02	7.05	6.45	6.37
Total Debt / EBITDA	3.32	3.54	2.99	3.1	2.96
Net Debt / EBITDA	3.05	3.21	2.59	2.61	2.63
Total Debt / (EBITDA - Capex)	3.48	3.7	3.09	3.23	3.1
Net Debt / (EBITDA - Capex)	3.19	3.35	2.68	2.73	2.76
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	-0.36	7.67	-1.35	-5.19	-0.99
Gross Profit, 1 Yr. Growth %	-1.13	8.37	-2.01	-4.89	-0.61
EBITDA, 1 Yr. Growth %	-0.79	1.63	7.26	-10.23	-0.54
EBITA, 1 Yr. Growth %	-0.43	6.33	7.67	-10.37	-0.76
EBIT, 1 Yr. Growth %	-0.43	6.33	8.49	-21.85	-0.41
Earnings From Cont. Operations, 1 Yr. Growth %	6.25	-1.84	-307.26	-122.42	144.11
Net Income, 1 Yr. Growth %	6.27	-1.99	-315.53	-121.35	153.06
Normalized Net Income, 1 Yr. Growth %	1.65	4.56	9.95	-10.2	-3.16
Diluted EPS Before Extra, 1 Yr. Growth %	5.99	-1.25	-321.51	-121.03	156.69
Accounts Receivable, 1 Yr. Growth %	8.51	-12.98	10.66	-1.11	7.95
Inventory, 1 Yr. Growth %	-11.99	7.43	-12.93	-6.52	-5.07
Net Property, Plant and Equip., 1 Yr. Growth %	-2.11	-1.74	-5.84	-4.45	2.37
Total Assets, 1 Yr. Growth %	-0.24	11.78	-22.68	0.15	-8.08
Tangible Book Value, 1 Yr. Growth %	-8.03	10.68	-19.94	3.81	-12.6
Common Equity, 1 Yr. Growth %	7.22	12.32	-30.25	-5.56	-3.46
Cash From Operations, 1 Yr. Growth %	-0.71	6.97	3.08	-5.5	-37.36
Capital Expenditures, 1 Yr. Growth %	3.13	-0.76	-12.05	5.65	13.37
Levered Free Cash Flow, 1 Yr. Growth %	-0.81	-0.63	5.78	38.53	-70.87
Unlevered Free Cash Flow, 1 Yr. Growth %	-3.16	0.99	6.64	32.94	-63.97
Dividend Per Share, 1 Yr. Growth %	2.47	1.02	2	2	2
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	-0.37	3.58	3.07	-3.29	-3.11
Gross Profit, 2 Yr. CAGR %	-0.77	3.51	3.05	-3.93	-2.77
EBITDA, 2 Yr. CAGR %	2.3	0.62	6.03	-2.54	-5.85
EBITA, 2 Yr. CAGR %	2.78	2.7	7.03	-1.58	-5.27
EBIT, 2 Yr. CAGR %	2.78	2.7	7.65	-7.71	-3.93
Earnings From Cont. Operations, 2 Yr. CAGR %	9.19	2.13	42.64	-31.83	-26.02
Net Income, 2 Yr. CAGR %	9.19	2.06	45.34	-32.16	-26.49
Normalized Net Income, 2 Yr. CAGR %	2.94	2.87	7.67	-0.37	-11.08
Diluted EPS Before Extra, 2 Yr. CAGR %	8.96	2.3	47.9	-31.74	-26.52
Accounts Receivable, 2 Yr. CAGR %	-5.67	-2.83	-1.87	4.61	3.32
Inventory, 2 Yr. CAGR %	-6.93	-2.76	-3.28	-9.78	-5.8
Net Property, Plant and Equip., 2 Yr. CAGR %	-5.26	-1.93	-3.81	-5.15	-1.1
Total Assets, 2 Yr. CAGR %	-1.3	5.6	-7.04	-12	-4.05
Tangible Book Value, 2 Yr. CAGR %	-6.05	0.89	-5.87	-8.84	-4.75
Common Equity, 2 Yr. CAGR %	2.54	9.74	-11.49	-18.84	-4.52
Cash From Operations, 2 Yr. CAGR %	3.93	3.06	5	-1.3	-23.06
Capital Expenditures, 2 Yr. CAGR %	-10.91	1.17	-6.57	-3.6	9.45
Levered Free Cash Flow, 2 Yr. CAGR %	27.02	-0.08	6.07	20.14	-56.87
Unlevered Free Cash Flow, 2 Yr. CAGR %	20.33	-0.67	6.77	18.28	-51.21
Dividend Per Share, 2 Yr. CAGR %	3.06	1.74	4.52	5.03	2
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	1.6	2.24	1.91	0.24	-2.53
Gross Profit, 3 Yr. CAGR %	1.96	2.19	1.63	0.33	-2.84
EBITDA, 3 Yr. CAGR %	3.29	2.22	3.7	0.04	-1.88
EBITA, 3 Yr. CAGR %	3.12	3.82	4.44	0.61	-1.31
EBIT, 3 Yr. CAGR %	3.12	3.82	4.93	-3.52	-5.34
Earnings From Cont. Operations, 3 Yr. CAGR %	3.94	5.39	29.3	-23.02	4.29
Net Income, 3 Yr. CAGR %	4.08	5.33	30.94	-23.31	5.21
Normalized Net Income, 3 Yr. CAGR %	3.3	3.32	5.68	1.03	-1.3
Diluted EPS Before Extra, 3 Yr. CAGR %	3.95	5.44	32.35	-22.8	6.15
Accounts Receivable, 3 Yr. CAGR %	1.49	-8.17	1.47	-1.62	5.71
Inventory, 3 Yr. CAGR %	-4.33	-2.37	-6.28	-4.38	-8.24
Net Property, Plant and Equip., 3 Yr. CAGR %	-1.39	-4.1	-3.25	-4.02	-2.7
Total Assets, 3 Yr. CAGR %	-2.09	2.88	-4.82	-4.7	-10.71
Tangible Book Value, 3 Yr. CAGR %	-6.13	-0.77	-6.59	-2.75	-10.11
Common Equity, 3 Yr. CAGR %	0.88	5.7	-5.65	-9.56	-14.01
Cash From Operations, 3 Yr. CAGR %	-1.91	4.93	3.07	1.38	-15.18
Capital Expenditures, 3 Yr. CAGR %	-11.41	-7.65	-3.44	-2.66	1.75
Levered Free Cash Flow, 3 Yr. CAGR %	-5.71	17.55	3.8	15.99	-25.09
Unlevered Free Cash Flow, 3 Yr. CAGR %	-5.36	13.84	3.38	14.9	-20.41
Dividend Per Share, 3 Yr. CAGR %	3.37	2.37	3.83	3.67	4.01
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	12.69	7.17	2.18	-0.01	-0.13
Gross Profit, 5 Yr. CAGR %	15.19	9.48	2.39	-0.11	-0.15
EBITDA, 5 Yr. CAGR %	15.73	9.07	4.15	0.72	-0.25
EBITA, 5 Yr. CAGR %	15.27	10.2	5.12	1.91	0.1
EBIT, 5 Yr. CAGR %	15.92	10.2	4.73	-1.21	-2.27
Earnings From Cont. Operations, 5 Yr. CAGR %	7.58	-28.89	17.97	-11.47	3.42
Net Income, 5 Yr. CAGR %	7.91	-29.21	18.95	-11.66	3.94
Normalized Net Income, 5 Yr. CAGR %	7.73	-19.72	4.83	1.59	0.33
Diluted EPS Before Extra, 5 Yr. CAGR %	3.47	-30.71	19.69	-11.39	4.59
Accounts Receivable, 5 Yr. CAGR %	2.15	-4.63	0.13	-3.26	2.21
Inventory, 5 Yr. CAGR %	-1.84	-0.67	-3.91	-5.4	-6.09
Net Property, Plant and Equip., 5 Yr. CAGR %	6.23	-0.06	-2.37	-4.52	-2.39
Total Assets, 5 Yr. CAGR %	28.13	1.71	-4.1	-3.35	-4.51
Tangible Book Value, 5 Yr. CAGR %	64.53	-1.22	-6.02	-4.08	-5.86
Common Equity, 5 Yr. CAGR %	52.66	4.43	-4.26	-4.9	-5.2
Cash From Operations, 5 Yr. CAGR %	16.08	14.22	0.8	2.39	-8.31
Capital Expenditures, 5 Yr. CAGR %	-2.1	-7.94	-9.51	-6.05	1.52
Levered Free Cash Flow, 5 Yr. CAGR %	20.13	8.05	-1.23	20.2	-14.69
Unlevered Free Cash Flow, 5 Yr. CAGR %	19.91	8.12	-0.8	16.91	-11.93
Dividend Per Share, 5 Yr. CAGR %	4.94	16.82	3.83	3.43	3.1